Novo Holdings

Private credit took the lead today with $1 billion put to work, much of it toward high-end multi-family/retail mixed-used developments.

Medical devices, biotechnology and medtech platforms accounted for most of the private equity and VC investment we tracked today, some of it coming from firms focused partly on entirely on the sector.

AW Research tracked about $28.5 billion in private market deals across credit, equity, infrastructure and real estate in the week ending March 17.

AW Research tracked about $1 billion in private market deals across credit, equity, infrastructure and real estate in the week ending Feb. 24.

Divided by asset class, AW Research tracked a total of roughly $9.4 billion in deals publicly announced in the five-day period for the week ending Feb. 17. Credit: $6 billion Crayhill Capital Management provided a $200 million secured receivables financing facility to ...

Divided by asset class, Alternatives Watch tracked about $4.4 billion in alternative investment deals announced in the week ending Jan. 20.

Divided by asset class, Alternatives Watch tracked a total of roughly $1.8 billion in deals publicly announced in the five-day period for the week ending Jan. 6. Private equity: $1.5 billion Triwise Capita led $25 million Series B extension financing round for ...

Divided by asset class, Alternatives Watch tracked about $19.3 billion in private market deals announced in the week ending Dec. 16.

Divided by asset class, Alternatives Watch tracked a total of roughly $9.4 billion in deals publicly announced in the five-day period for the week ending Dec. 2. Private equity: $7.7 billion KKR via the KKR Asia IV Fund completed a tender offer ...

Divided by asset class, Alternatives Watch tracked about $4.6 billion in alternative investment deals announced in the week ending Nov. 11.